Evidence map›Paper›PMID 40006039›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Discovery of Biofilm-Inhibiting Compounds to Enhance Antibiotic Effectiveness Against

Elizaveta Dzalamidze, Mylene Gorzynski, Rebecca Vande Voorde, Dylan Nelson, Lia Danelishvili

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Critical reviews in microbiology · 2026
    Review
  2. Article
  3. Microorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elizaveta DzalamidzeDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
Mylene GorzynskiDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
Rebecca Vande VoordeDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
Dylan NelsonDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA.
Lia DanelishviliDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.ORCID 0000-0003-1390-3121

Funding

Targeting the LpqY-SugABC transporter system for synergistic anti-TB compoundsR15AI142609 · NIAID · OREGON STATE UNIVERSITY · PI DANELISHVILI, LIA · 2019 to 2019
$444k
NIAID NIH HHS 1R15AI142609-01A1NIAID NIH HHS R15 AI142609
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofilmhigh-throughput screeningintracellular killingmacrophageMycobacterium abscessusnontuberculous mycobacteriaNTMsmall molecules

Identifiers

PMID40006039
PMCPMC11859778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.